{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2009-D-0137\" and posted_year = 2016 sorted by posted_date descending", "rows": [["FDA-2009-D-0137-0028", "FDA", "FDA-2009-D-0137", "Amendment to Guidance for Industry: Use of Serological Tests To Reduce\nthe Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components Intended for Transfusion; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-11-10T05:00:00Z", 2016, 11, "2016-11-10T05:00:00Z", "2017-02-09T04:59:59Z", "2017-02-07T02:02:05Z", "2016-27107", 0, 0, "0900006482387508"], ["FDA-2009-D-0137-0036", "FDA", "FDA-2009-D-0137", "Reference 7 Donors deferred for self-reported Chagas disease history:\ndoes it reduce risk?", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:11Z", null, 0, 0, "09000064823877ec"], ["FDA-2009-D-0137-0031", "FDA", "FDA-2009-D-0137", "Reference 2-Autochthonous Transmission of Trypanosoma cruzi, Louisiana", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:30:56Z", null, 0, 0, "0900006482387a72"], ["FDA-2009-D-0137-0038", "FDA", "FDA-2009-D-0137", "Reference 9 Trypanosoma cruzi (E. coli Recombinant) Antigen ABBOTT PRISM Chagas Package Insert (2010)", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:17Z", null, 0, 0, "09000064823877ee"], ["FDA-2009-D-0137-0029", "FDA", "FDA-2009-D-0137", "Amendment to \u201cGuidance for Industry: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components Intended for Transfusion\u201d", "Other", "Guidance", "2016-11-10T05:00:00Z", 2016, 11, "2016-11-10T05:00:00Z", "2017-02-09T04:59:59Z", "2024-11-12T06:15:55Z", null, 1, 0, "0900006482387a6f"], ["FDA-2009-D-0137-0039", "FDA", "FDA-2009-D-0137", "Reference 10  FDA Blood Products Advisory Committee T. cruzi Incidence Study in Blood Donors and its Implications for One-time Testing of Blood Donors August 2 2011", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:20Z", null, 0, 0, "09000064823877ef"], ["FDA-2009-D-0137-0042", "FDA", "FDA-2009-D-0137", "Reference 13 Trypanosoma cruzi (E coli) Recombinant Antigen ABBOTT ESA Chagas Package Insert 2011", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:29Z", null, 0, 0, "09000064823877f2"], ["FDA-2009-D-0137-0035", "FDA", "FDA-2009-D-0137", "Reference 6-Epidemiology of American Trypanosomiasis (Chagas Disease)", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:08Z", null, 0, 0, "09000064823877eb"], ["FDA-2009-D-0137-0037", "FDA", "FDA-2009-D-0137", "Reference 8 Trypanosoma cruzi (T cruzi) Whole Cell Lysate Antigen ORTHO T cruzi ELISA Test System Package Insert 2009", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:15Z", null, 0, 0, "09000064823877ed"], ["FDA-2009-D-0137-0032", "FDA", "FDA-2009-D-0137", "Reference 3-Case Report: Evidence of Autochthonous Chagas Disease in Southeastern Texas", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:30:58Z", null, 0, 0, "0900006482387a73"], ["FDA-2009-D-0137-0033", "FDA", "FDA-2009-D-0137", "Reference 4-An Estimate of the Burden of Chagas Disease in the United States", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:02Z", null, 0, 0, "0900006482387a74"], ["FDA-2009-D-0137-0034", "FDA", "FDA-2009-D-0137", "Reference 5-Trypanosoma cruzi infection in North America and Spain:\nevidence in support of transfusion transmission", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:05Z", null, 0, 0, "09000064823877ea"], ["FDA-2009-D-0137-0040", "FDA", "FDA-2009-D-0137", "Reference 11 FDA Blood Products Advisory Committee Reentry of blood donors deferred on the basis of screening test results for antibodies to T. cruzi July 31 2014", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:23Z", null, 0, 0, "09000064823877f0"], ["FDA-2009-D-0137-0030", "FDA", "FDA-2009-D-0137", "AMENDMENT TO \u201cGUIDANCE FOR INDUSTRY: USE OF SEROLOGICAL TESTS TO REDUCE THE RISK OF TRANSMISSION OF TRYPANOSOMA CRUZI INFECTION IN WHOLE BLOOD AND BLOOD COMPONENTS INTENDED FOR TRANSFUSION\u201d DRAFT GUIDANCE FOR INDUSTRY", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:30:52Z", null, 0, 0, "0900006482387a71"], ["FDA-2009-D-0137-0041", "FDA", "FDA-2009-D-0137", "Reference 12 FDA Blood Products Advisory Committee Potential Testing Strategies for T. cruzi Infection in Blood Donors April 1 2009", "Supporting & Related Material", "Background Material", "2016-11-10T05:00:00Z", 2016, 11, null, null, "2016-11-10T15:31:26Z", null, 0, 0, "09000064823877f1"]], "truncated": false, "filtered_table_rows_count": 15, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2009-D-0137", "p1": "2016"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016", "results": [{"value": "FDA", "label": "FDA", "count": 15, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016", "results": [{"value": 2016, "label": 2016, "count": 15, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&_facet=subtype"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2009-D-0137&posted_year=2016&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1852.4903849465773, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}